Impurity Supplier in India
Impurities manufacture from India called Rxn chemicals , having largest export worldwide like USA, Canada,China,Europe, Middle east and Asian countries.
Ketoprofen Impurity E | 59512-16-2 | C16H15NO2 | 253.3 |
Ketoprofen Impurity F | C16H13NO | 235.29 | |
Ketoprofen Impurity G | C10H9NO2 | 175.19 | |
Ketoprofen Impurity H | C9H7NO2 | 161.16 | |
Ketoprofen Impurity I | C15H11NO | 221.26 | |
Ketoprofen Impurity J | C18H18O3 | 282.34 | |
Ketoprofen Methyl Ester | C17H16O3 | 268.32 | |
Ketoprofen Impurity D | 107257-20-5 | C17H16O3 | 268.32 |
Ketoprofen Related Compound C | 68432-95-1 | C10H10O4 | 194.19 |
Ketoprofen Lysinate | 57469-78-0 | C16H14O3. C6H14N2O2 | 254.29 146.19 |
Ketoprofen Ethyl Ester | 60658-04-0 | C18H18O3 | 282.34 |
Ketoprofen Sodium Salt | 57495-14-4 | C16H13O3 Na | 253.28 22.99 |
R-Ketoprofen | 56105-81-8 | C16H14O3 | 254.29 |
(S)-Ketoprofen Tromethamine Salt (Dexketoprofen Trometamol) | 156604-79-4 | C16H14O3. C4H11NO3 | 254.29 121.14 |
Ketoprofen Related Compound D | 66067-44-5 | C15H12O2 | 224.26 |
Ketoprofen-13C-D3 | C15H11O313CD3 | 258.3 | |
Ketoprofen metabolite | C16H16O3 | 256.3 | |
(S)-Ketoprofen | C16H14O3 | 254.29 | |
rac-Ketoprofen acyl-beta-D-glucuronide (mixture of isomers) | 76690-94-3 | C22H22O9 | 430.42 |
(S)-(+)-Ketoprofen-d3 Tromethamine Salt | C16H11O3D3.C4H11NO3 | 257.31 121.14 | |
(S)-(+)-Ketoprofen-d3 | C16H11O3D3 | 257.31 | |
4-Hydroxy ketorolac | 111930-01-9 | C15H13NO4 | 271.28 |
Ketorolac Impurity H | C16H15NO3 | 269.3 | |
Ketorolac Impurity I | C14H13NO | 211.27 | |
Ketorolac Impurity J | C17H17NO3 | 283.33 | |
Ketorolac | 74103-06-3 | C15H13NO3 | 255.28 |
Ketorolac-d5 | 74103-06-3(non-d) | C15H8NO3D5 | 260.31 |
1-Keto Ketorolac | 113502-52-6 | C14H11NO2 | 225.25 |
Ketorolac Impurity A | 154476-25-2 | C14H13NO2 | 227.27 |
Ketorolac Impurity C | 1026936-07-1 | C15H13NO3 | 255.28 |
Ketorolac Impurity F | C15H13NO3 | 255.28 | |
Ketorolac Impurity D | 1391053-45-4 | C16H15NO4 | 285.3 |
Ketorolac Impurity G | C16H15NO4 | 285.3 | |
Ketorolac Impurity E | C19H22N2O5 | 358.4 | |
KF31327 | 220060-39-9 | C24H28N6OS | 448.59 |
Kynurenic-d5 Acid | C10H2NO3D5 | 194.2 | |
Ketotifen Fumarate | C19H19NOS.C4H4O4 | 309.43 116.07 | |
Ketotifen Impurity A | C19H19NS | 293.43 | |
Ketotifen Impurity B | C20H23NO2S | 341.48 | |
Ketotifen Impurity C | C19H21NO2S | 327.45 | |
Ketotifen Impurity D | 88456-70-6 | C19H19NO2S | 325.43 |
Ketotifen Impurity E | C19H19NOS | 309.43 | |
Ketotifen Impurity F | C19H19NOS | 309.43 | |
Ketotifen Impurity G | C19H17NO2S | 323.42 | |
Kojic Acid | C6H6O4 | 142.11 | |
Ketanserin | 74050-98-9 | C22H22FN3O3 | 395.44 |
Lamotrigine-13C3 | 84057-84-1(non-d) | C613C3H7Cl2N5 | 259.07 |
Lamotrigine Dimer Impurity 2 | C19H14Cl4N10 | 524.2 | |
Lamotrigine-13C-d3 | C9H4Cl2N5D3 | 260.1 | |
Lamotrigine Impurity D | 661463-79-2 | C9H5Cl2N3O2 | 258.07 |
Lamotrigine Related Compound C | C9H6Cl2N4O | 257.08 | |
Lamotrigine Related Compound D | C16H9Cl4N5O | 429.1 | |
Lamotrigine Impurity C | 94213-23-7 | C9H7Cl2N5 | 256.1 |
Lamotrigine Impurity | N/A | C8H3Cl2NO | 200.03 |
Lamotrigine Impurity E (2,3-Dichlorobenzoic Acid) | 50-45-3 | C7H4Cl2O2 | 191.01 |
Lamotrigine Dimer Impurity 1 | C19H14Cl4N10 | 524.2 | |
Lacidipine-d9 | 103890-78-4 | C26H24NO6D9 | 464.61 |
Lacidipine | 103890-78-4 | C26H33NO6 | 455.56 |
Lacidipine-d10 | 103890-78-4(non-d) | C26H23NO6D10 | 465.62 |
Dehydro lacidipine | C26H31NO6 | 453.54 | |
cis-Lacidipine | 103890-79-5 | C26H33NO6 | 455.55 |
Lansoprazole | 103577-45-3 | C16H14F3N3O2S | 369.37 |
Lansoprazole EP Impurity C | 103577-40-8 | C16H14F3N3OS | 353.37 |
Lansoprazole EP Impurity D | 615-16-7 | C7H6N2O | 134.14 |
Lansoprazole EP Impurity E | 583-39-1 | C7H6N2S | 150.2 |
Lansoprazole EP Impurity F | 168167-42-8 | C14H12ClN3OS | 305.79 |
Lansoprazole Sulfone N-Oxide | C16H14F3N3O4S | 401.37 | |
2-Chloromethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine | C9H9ClF3NO | 239.63 | |
Lansoprazole Impurity H | 1346598-28-4 | C23H16F3N5OS | 467.48 |
Lansoprazole Impurity I | N/A | C23H16F3N5OS | 467.48 |
Lansoprazole N-Trifuoroethyl Impurity | 1187926-84-6 | C18H15F6N3O2S | 451.39 |
Lansoprazole EP Impurity B (Lansoprazole Sulfone) | 131926-99-3 | C16H14F3N3O3S | 385.37 |
Lansoprazole N-(3-Methyl-4-Trifuoroethoxyl-Pyridin-2-yl) Impurity | N/A | C25H22F6N4O3S | 572.53 |
(R)-Lansoprazole-d4 | 1246819-33-9 | C16H12F3N3O2SD4 | 375.41 |
Lansoprazole Thioxo Impurity | 1246819-06-6 | C14H9N3OS | 267.31 |
Lansoprazole Related Compound 1 | C14H13N3OS | 271.34 | |
Lansoprazole Related Compound 2 (Des(trifluoroethyl) Lansoprazole Sulfide) | 131926-97-1 | C14H13N3OS | 271.34 |
Lansoprazole Related Compound 3 | 1083100-27-9 | C25H22F6N4O2S | 556.53 |
5-Hydroxy Lansoprazole | 131926-98-2 | C16H14F3N3O3S | 385.37 |
Lansoprazole-d4 | 103577-45-3(non-d) | C16H10F3N3O2SD4 | 373.39 |
5-Hydroxy Lansoprazole Sulfide | C16H14F3N3O2S | 369.37 | |
6-Hydroxy Lansoprazole Sulfide | C16H14F3N3O2S | 369.37 | |
(R)-(+)-Lansoprazole | C16H14F3N3O2S | 369.37 | |
Lansoprazole Glucuronide | N/A | C22H22F3N3O8S | 545.5 |
Lansoprazole EP Impurity A | 213476-12-1 | C16H14F3N3O3S | 385.37 |
Leflunomide | 75706-12-6 | C12H9F3N2O2 | 270.21 |
Leflunomide Impurity F | C12H9F3N2O2 | 270.21 | |
Leflunomide Impurity G | C12H12N2O2 | 216.24 | |
Leflunomide Impurity H | 24522-30-3 | C10H7F3N2O | 228.18 |
Leflunomide-d4 | 75706-12-6 (non-d) | C12H5F3N2O2D4 | 274.24 |
2-Cyano-3OH-N-(4-trifluoromethylphenyl) crotonamide | 163451-81-8 | C12H9F3N2O2 | 270.21 |
2-Cyano-3OH-N-(4-trifluoromethylphenyl) crotonamide-d4 | 108605-62-5 | C12H5F3N2O2D4 | 274.24 |
Leflunomide Impurity E | C12H9F3N2O2 | 270.21 | |
Leflunomide Impurity B | 163451-81-8 | C12H9F3N2O2 | 270.21 |
Leflunomide Impurity C | 61643-23-0 | C12H9F3N2O2 | 270.21 |
Leflunomide Impurity A | 455-14-1 | C7H6F3N | 161.13 |
Leflunomide Impurity D | 42831-50-5 | C5H5NO3 | 127.1 |
Levetiracetam | 102767-28-2 | C8H14N2O2 | 170.21 |
Levetiracetam-d6 | 102767-28-2(non-d) | C8H8D6N2O2 | 176.25 |
Levetiracetam Metabolite | 102849-49-0 | C8H13NO3 | 171.2 |
Levetiracetam Impurity B | 358629-47-7 | C8H12N2O2 | 168.2 |
Levetiracetam Impurity C | 72762-00-6 | C5H5NO | 95.1 |
Levetiracetam Impurity D | 103765-01-1 | C8H14N2O2 | 170.21 |
Levetiracetam Imurity (L-2-Aminobutanamide HCl,S-2-Aminobutanamide HCl) | C4H10N2O.HCl | 102.14 36.46 | |
Levetiracetam Impurity 3 | N/A | C8H15ClN2O2 | 206.67 |
Levetiracetam Impurity A | 67118-31-4 | C8H13NO3 | 171.2 |
Lidocaine-d6 HCl | 1215823-29-2 (free base)) | C14H16N2OD6. HCl | 240.38 36.46 |
Lidocaine Impurity F | C14H22N2O . HCl | 234.34 36.46 | |
Lidocaine Impurity G | C13H20N2O . HCl | 220.32 36.46 | |
Lidocaine Impurity K | 50295-20-0 | C13H20N2O. HCl | 220.32 36.46 |
3'-Hydroxy Lidocaine | 34604-55-2 | C14H22N2O2 | 250.34 |
Lidocaine Impurity A | C8H11N | 121.18 | |
Lidocaine Impurity C | 2198-53-0 | C10H13NO | 163.22 |
Lidocaine Impurity H | C10H12ClNO | 197.67 | |
Lidocaine Impurity I | C14H22N2O | 234.34 | |
Monoethylglycinexylidine HCl (Impurity D) | 7729-94-4 | C12H18N2O.HCl | 206.29 36.46 |
Lidocaine Impurity J | N/A | C14H22N2O | 234.34 |
Lidocaine Impurity 1 (2-(Diethylamino)-N-(Diethylaminoyl)acetamide) | N/A | C11H23N3O2 | 229.32 |
Lidocaine Impurity 2 (2-[(Diethylcarbamoyl)amino]-N, N-Diethylacetamide) | N/A | C11H23N3O2 | 229.32 |
Lidocaine Impurity 3 | C14H19N3 | 229.33 | |
Lidocaine | 137-58-6 | C14H22N2O | 234.34 |
Lidocaine Dichloro Impurity | 39084-88-3 | C10H11Cl2NO | 232.11 |
Monoethyl Glycinexylidine-d6 HCl | 1216698-89-3 (free base) | C12H12N2OD6. HCl | 212.33 36.46 |
Glycinexylidide HCl | 18865-38-8 | C10H14N2O.HCl | 178.24 36.46 |
Glycinexylidide-d6 | 18865-38-8(non-d) | C10H8N2OD6 | 184.27 |
Lidocaine-d10 | 137-58-6 (non-d) | C14H12N2OD10 | 244.4 |
2,6-Xylidine-d6 HCl | C8H5ND6. HCl | 127.22 36.46 | |
Lidocaine Impurity B (Lidocaine N-Oxide) | 2903-45-9 | C14H22N2O2 | 250.34 |
Lidocaine Impurity E | 745798-07-6 | C20H25N3O2 | 339.44 |
Linezolid-d3 | 1127120-38-0 | C16H17FN3O4D3 | 340.37 |
Thio Linezolid (Linezolid Related Compound B) | N/A | C16H20FN3O3S | 353.42 |
Linezolid Related Compound A | 168828-84-0 | C14H16FN5O3 | 321.31 |
Linezolid Related Compound C | 168828-90-8 | C14H18FN3O3 | 295.32 |
Defluoro Linezolid | 556801-15-1 | C16H21N3O4 | 319.36 |
Linezolid Impurity D HCl | 1391068-25-9 | C15H22FN3O3. HCl | 311.36 36.46 |
Linezolid Dimer | 908143-04-4 | C30H35F2N5O7 | 615.64 |
R-Linezolid-d3 | 1127120-38-0 | C16H17FN3O4D3 | 340.37 |
Linezolid Impurity (N,O-Desethylene Linezolid) | 1219708-30-1 | C14H18FN3O4 | 311.32 |
Linezolid impurity PNU177636 | C20H26FN3O5 | 407.45 | |
Linezolid Related Compound (Linezolid N-Oxide) | 189038-36-6 | C16H20FN3O5 | 353.35 |
Linezolid-13C-d3 | 165800-03-3 | C1513CH17D3FN3O4 | 341.36 |
Linezolid related Compound | 174649-09-3 | C15H19FN2O6S | 374.39 |
Linezolid Related Impurity 1 | 1532560-87-4 | C13H20FN3O2 | 269.32 |
Linezolid Impurity 7 HCl | 333753-71-2 (free base) | C15H22FN3O3. HCl | 311.36 36.46 |
Racemic-Linezolid Impurity PNU140155 | C15H22FN3O3 | 311.36 | |
Linezolid Related Impurity 2 HCl | C15H22FN3O3. HCl | 311.36 36.46 | |
Linezolid | 165800-03-3 | C16H20FN3O4 | 337.35 |
Linezolid-13C2-d3 | C16H17FN3O4D3 | 342.35 | |
Benzyl 3-Fluoro-4-(4-morpholinyl)phenyl)carbamate | 168828-81-7 | C18H19FN2O3 | 330.36 |
Linezolid Impurity ((5R)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-5-hydroxymethyl-2-oxazolidinone) | 168828-82-8 | C14H17FN2O4 | 296.3 |
R-Linezolid | 872992-20-6 | C16H20FN3O4 | 337.35 |
Linezolid Impurity PNU140155 | C15H22FN3O3 | 311.36 | |
Lisinopril-d5 | 83915-83-7 | C21H26N3O5D5 | 410.53 |
Lisinopril Impurity C ((S, S, S)-Diketopiperazine) | 328385-86-0 | C21H29N3O4 | 387.48 |
Lisinopril | C21H31N3O5 | 405.5 | |
Lisinopril Impurity A | NA | C10H13NO2 | 179.22 |
Lisinopril Impurity D | NA | C21H29N3O4 | 387.48 |
Lisinopril Impurity E | 85955-59-5 | C21H31N3O5 | 405.5 |
Lisinopril Impurity F | NA | C21H37N3O5 | 411.55 |
Lisinopril CPP Lysine Impurity | 138247-43-5 | C16H24N2O4 | 308.38 |
Lisinopril Impurity H (Dimer Impurity) | N/A | C37H53N5O8 | 695.86 |
Loxapine | 54810-23-0 | C18H18ClN3O | 327.82 |
Loxapine-d8 | 54810-23-0(non-d) | C18H10ClN3OD8 | 335.86 |
Loxapine N+-Glucuronide | C24H27ClN3O7 | 504.95 | |
Loxapine N-Oxide | 25967-34-4 | C18H18ClN3O2 | 343.82 |
7-Hydroxy-Loxapine | N/A | C18H18ClN3O2 | 343.82 |
7-Hydroxy-Loxapine-d8 | N/A | C18H10ClN3O2D8 | 351.86 |
7-Hydroxy-Loxapine N-Oxide | N/A | C18H18ClN3O3 | 359.82 |
7-Hydroxy-Loxapine Sulfate | N/A | C18H18ClN3O5S | 423.88 |
7-Hydroxy-Loxapine-O-Glucuronide | N/A | C24H26ClN3O8 | 519.94 |
8-Hydroxy Loxapine | 61443-77-4 | C18H18ClN3O2 | 343.82 |
8-Hydroxy-Loxapine-d8 | N/A | C18H10ClN3O2D8 | 351.86 |
8-Hydroxy-Loxapine N-Oxide | N/A | C18H18ClN3O3 | 359.82 |
8-Hydroxy-Loxapine Sulfate | N/A | C18H18ClN3O5S | 423.88 |
8-Hydroxy-Loxapine-O-Glucuronide | N/A | C24H26ClN3O8 | 519.94 |
Lurasidone Hydrochloride | 367514-88-3 | C28H36N4O2S | 492.69 |
Lurasidone-d8 | C28H28N4O2SD8 | 500.74 | |
Lurasidone Inactive Metabolite 14283 | C28H36N4O3S | 508.69 | |
Lurasidone Inactive Metabolite 14326 | C28H36N4O3S | 508.69 | |
Lurasidone Inactive Metabolite 14283-d8 | N/A | C28H28N4O3SD8 | 516.74 |
Lurasidone Inactive Metabolite 14326-d8 | N/A | C28H28N4O3SD8 | 516.74 |
Lurasidone Sulfoxide | C28H36N4O3S | 508.69 | |
Loperamide HCl | 34552-83-5 | C29H33ClN2O2.HCl | 513.51 |
Lapachol | 84-79-7 | C15H14O3 | 242.28 |
Desmethyl Loperamide | 66164-07-6 | C28H31ClN2O2 | 463.02 |
2̢۪-O-Methyl Lactose | 77667-98-2 | C13H24O11 | 356.33 |
Loperamide-d6 HCl | 34552-83-5 (non-d) | C29H27ClN2O2D6 | 483.09 |
Lincomycin B HCl | 11021-35-5 | C17H32N2O6S HCl | 392.52 36.46 |
epi-Lincomycin-2,7-dipalmitate | C51H95NO8S | 882.39 | |
Lincomycin-2,7-dipalmitate | C51H95NO8S | 882.39 | |
Lincomycin impurity A | C18H34N2O6S | 406.55 | |
Lincomycin impurity C | C17H32N2O6S | 392.52 | |
Lincomycin 2,4-Phosphate | N/A | C18H33N2O8PS | 468.51 |
7-epi Lincomycin | 26389-84-4 | C18H34N2O6S | 406.55 |
Loperamide N-Oxide | NULL | C29H33ClN2O3 | 493.05 |
Lumiflavin | 1088-56-8 | C13H12N4O2 | 256.27 |
Loperamide Impurity A | N/A | C35H37ClN2O2 | 553.15 |
Lorcaserin HCl Hemihydrate | 856681-05-5 | C11H14ClN. HCl. 0.5 H2O | 195.69 36.46 0.5 18.02 |
Lorcaserin-D4 | C11H10ClND4 | 199.72 | |
Lorcaserin impurity A | C11H14ClN | 195.69 | |
Lorcaserin impurity B | 953789-37-2 | C11H15Cl2N . HCl | 232.15 36.46 |
Lorcaserin impurity C | C13H16ClNO | 237.73 | |
Lorcaserin impurity D | 1030624-36-2 | C11H14ClNO2 | 227.69 |
Lorcaserin impurity E | C11H14ClN . C4H6O6 | 195.69 150.09 | |
Lorcaserin Dechloro Impurity | N/A | C11H15N | 161.25 |
Lorcaserin N-Oxide Impurity | N/A | C11H14ClNO | 211.69 |
Lorcaserin Lactam Impurity | N/A | C11H12ClNO | 209.68 |
Lorcaserin 5-Methyl Isomer | N/A | C11H14ClN | 195.69 |
Lactitol Impurity B | N/A | C12H24O11 | 344.32 |
Loratadine (Desloratadine Impurity E) | 79794-75-5 | C22H23ClN2O2 | 382.89 |
3-Hydroxy Desloratadine Pyridine N-oxide | NULL | C19H19ClN2O2 | 342.83 |
3-Hydroxy desloratadine-d4 | C19H15ClN2OD4 | 330.85 | |
5-Hydroxy desloratadine | 117811-12-8 | C19H19ClN2O | 326.83 |
6-Hydroxy Desloratadine | 119410-05-8 | C19H19ClN2O | 326.83 |
3-Hydroxy Desloratadine | C19H19ClN2O | 326.83 | |
Desloratadine Pyridine N-Oxide | 169253-26-3 | C19H19ClN2O | 326.83 |
Desloratadine Impurity 1 | C19H19ClN2 | 310.83 | |
Desloratadine Impurity 2 | 117811-13-9 | C19H19ClN2 | 310.83 |
Desloratadine Impurity 3 | C19H19ClN2 | 310.83 | |
Desloratadine Impurity 4 | C20H21ClN2 | 324.86 | |
Loratadine EP Impurity D (Desloratadine) | 100643-71-8 | C19H19ClN2 | 310.83 |
Desloratadine Impurity 5 | 38092-88-5 | C20H21ClN2 | 324.86 |
Desloratadine Impurity 6 | 38092-90-9 | C20H21ClN2 | 324.86 |
Loratadine EP Impurity B | 31251-41-9 | C14H10ClNO | 243.69 |
Loratadine Impurity D | 38089-93-9 | C20H23ClN2O | 342.87 |
Loratadine Impurity E | 133330-60-6 | C14H9Cl2NO | 278.14 |
Loratadine EP Impurity A | 133284-74-9 | C22H25ClN2O3 | 400.91 |
Loratadine EP Impurity C | 165739-83-3 | C22H22Cl2N2O2 | 417.34 |
N-Formyl Desloratadine (Desloratadine Impurity D) | C20H19ClN2O | 338.84 | |
Loratadine EP Impurity G (Methyl Loratadine) | 38092-89-6 | C20H21ClN2 | 324.86 |
Iso Desloratadine HCl | 183198-49-4 (free base) | C19H19ClN2. HCl | 310.83 36.46 |
Loratadine-d5 | 1020719-57-6 | C22H18D5ClN2O2 | 387.92 |
Desloratadine N-Hydroxypiperidine | 1193725-73-3 | C19H19ClN2O | 326.83 |
Desloratadine Impurity Disodium Salt | N/A | C25H23ClN2O6. 2 Na | 482.92 2 22.99 |
Desloratadine Impurity A | 38092-95-4 | C19H20N2 | 276.38 |
Desloratadine Impurity B | 117796-50-6 | C19H19BrN2 | 355.28 |
Desloratadine Impurity C | 117811-20-8 | C19H17ClN2 | 308.81 |
4-[[3-[2-(3-Chlorophenyl)ethyl]-2-pyridinyl]carbonyl]-1-piperidinecarboxylic Acid | 107256-32-6 | C20H21ClN2O3 | 372.85 |
11-Fluoro Desloratadine | 298220-99-2 | C19H20ClFN2 | 330.84 |
Descarboethoxy loratadine-d5 | 79794-75-5(non-d) | C19H14D5ClN2.HCl | 315.86 |
N-Acetyldesloratadine | 117796-52-8 | C21H21ClN2O | 352.87 |
Loratadine EP Impurity F | 125743-80-8 | C22H24ClFN2O2 | 402.9 |
12-Hydroxy Loratadine | C22H25ClN2O3 | 400.91 | |
3-Hydroxy desloratadine HCl | 19410-08-1 | C19H19ClN2O.HCl | 326.83 36.46 |
4-Hydroxymethyl loratadine | 609806-40-8 | C23H2ClN2O3 | 412.91 |
3-Hydroxy desloratadine glucuronide | 774538-89-5 | C25H27ClN2O7 | 502.96 |
2-Hydroxymethyl loratadine | 609806-39-5 | C23H2ClN2O3 | 412.91 |
Losartan potassium salt | 124750-99-8 | C22H22ClKN6O | 461.01 |
Losartan Impurity J | 1006062-27-6 | C24H25ClN6O2 | 464.96 |
Losartan Impurity K | 1159977-26-0 | C21H20Cl2N6 | 427.34 |
Losartan N1-Glucuronide | C28H31ClN6O7 | 599.05 | |
Losartan Carboxylic Acid Acyl-Beta-D-Glucuronide | N/A | C29H31ClN6O7 | 611.06 |
Losartan Related Compound A | 1247750-67-0 | C22H20ClN3O | 377.88 |
Losartan Related Compound B | N/A | C22H22ClN3O | 379.89 |
Losartan Impurity C (Isolosartan) | 114799-13-2 | C22H23ClN6O | 422.92 |
Losartan Impurity (5-(4'-Methylbiphenyl-2-yl)-1-Trityl-1H-Tetrazole) | 124750-53-4 | C33H26N4 | 478.6 |
N-Trithyl Losartan | 124751-00-4 | C41H37ClN6O | 665.24 |
Losartan Carboxylic Acid | 124750-92-1 | C22H21ClN6O2 | 436.9 |
Losartan Impurity B | 1159977-48-6 | C44H44Cl2N12O2 | 843.83 |
Losartan Carboxaldehyde | 114798-36-6 | C22H21ClN6O | 420.91 |
Losartan Trityl Ether (Impurity I) | 1006062-28-7 | C41H37ClN6O | 665.24 |
Losartan Impurity D | C8H11ClN2O | 186.64 | |
Losartan Impurity E | C14H12N4 | 236.28 | |
Losartan Impurity F | C25H29ClN6O | 465 | |
Losartan-d4 | 124750-99-8(non-d) | C22H19D4ClN6O | 425.94 |
Losartan Carboxylic Acid-d4 | 1246820-62-1 | C22H17ClN6O2D4 | 440.93 |
Losartan N2-glucuronide | C28H31ClN6O7 | 599.05 | |
Losartan Potassium Impurity L | 230971-71-8 | C44H44Cl2N12O | 827.83 |
Losartan Potassium Impurity M | 230971-72-9 | C44H44Cl2N12O | 827.83 |
Losartan Impurity G | 165276-38-0 | C22H21ClN6 | 404.91 |
Lovastatin hydroxy acid sodium salt | 75225-51-3 | C24H37O6.Na | 444.55 |
Lovastatin Impurity F | C24H34O5 | 402.54 | |
Lovastatin 6'-Exomethylene Impurity | C24H34O5 | 402.54 | |
Lovastatin 6'-beta-Hydroxy Impurity | C24H36O6 | 420.55 | |
Des(2-methylbutyrate) lovastatin hydroxy acid sodium salt | 75225-51-3 | C19H29O5.Na | 360.43 |
Lovastatin-d3 Hydroxy Acid Sodium Salt | 1279029-75-2 | C24H34O6D3.Na | 424.58 22.99 |
Lovastatin-d9 | NULL | C24H27O5D9 | 413.61 |
Lovastatin-d9 hydroxy acid sodium salt | NULL | C24H28O6D9.Na | 430.61 22.99 |
Lovastatin-d3 | 1002345-93-8 | C24H33O5D3 | 407.5 |
Lovastatin | C24H36O5 | 404.55 | |
Hydroxy Lovastatin | N/A | C24H36O7 | 436.55 |
Lovastatin Dimer | C48H72O10 | 809.1 | |
Levocetirizine-d4 | 130018-77-8 | C21H21ClN2O3D4 | 392.92 |
N-Benzyl-2-[2-[(2-hydroxyethyl)amino]ethoxy]acetamide | 1391053-09-0 | C13H20N2O3 | 252.32 |
Levocetirizine Impurity 1 | C28H32ClN3O2 | 478.04 | |
4-Chlorobenzhydrylimine | NA | C13H10ClN | 215.68 |
2-Chlorobenzhydryl amine | 5267-39-0 | C13H12ClN | 217.7 |
N-Benzyl-2-chloro-N(chloroacetyl)acetamide | NA | C11H11Cl2NO2 | 260.12 |
[2-[4-[4-chlorophenylmethyl]-1-piperazinyl]-ethoxy]acetamide | NA | C15H22ClN3O2 | 311.81 |
1-Benzylaziridin-2-one | NA | C9H9NO | 147.18 |
2-(p-Chlorobenzhydryl piperazine)-[(N,N'-bis(2-ethoxy acetic acid)] | NA | C25H32ClN2O6 | 492 |
Levocetetrizine N-Oxide | NA | C21H25ClN2O4 | 404.9 |
levocetirizine Impurity | C17H19ClN2 | 286.81 | |
Linuron-d6 | 330-55-2 (non-d) | C9H4Cl2N2O2D6 | 255.13 |
Letrozole-d4 | 1133712-96-5 | C17H7N5D4 | 289.33 |
Carbinol Metabolite of Letrozole | 134521-16-7 | C15H10N2O | 234.26 |
Letrozole | 112809-51-5 | C17H11N5 | 285.31 |
Letrozole Related Compound A | 112809-52-6 | C17H11N5 | 285.31 |
Letrozole Impurity B | 113402-31-6 | C22H13N3 | 319.39 |
Letrozole Impurity C | 112809-25-3 | C10H8N4 | 184.2 |
R-Lercanidipine | NULL | C36H41N3O6 | 611.74 |
Lercanidipine Impurity A | C19H22N2O6 | 374.4 | |
Lercanidipine Impurity | C21H26N2O6 | 402.45 | |
Lercanidipine Dimethyl Ester Impurity | N/A | C17H18N2O6 | 346.34 |
Lercanidipine Ethyl Methyl Ester Impurity (Impurity 5) | 39562-70-4 | C18H20N2O6 | 360.37 |
Lercanidipine Ethyl Impurity (Impurity 4) | N/A | C37H43N3O6 | 625.77 |
Lercanidipine Impurity 6 | C36H41N3O6 | 611.74 | |
R-Lercanidipine-d3 | NULL | C36H38D3N3O6 | 614.74 |
S-Lercanidipine | NULL | C36H41N3O6 | 611.74 |
S-Lercanidipine-d3 | NULL | C36H38N3O6 | 614.74 |
Lercanidipine Impurity D HCl (Dehydro Lercanidipine HCl) | 887769-34-8 (free base) | C36H39N3O6.HCl | 609.73 36.46 |
Lercanidipine HCl | 132866-11-6 | C36H41N3O6.HCl | 611.74 36.46 |
Lercanidipine Impurity B | 1119226-97-9 | C35H37N3O6 | 595.7 |
Lercanidipine-13C-d3 HCl | C35H38N3O613CD3. HCl | 615.75 36.46 | |
Lercanidipine Impurity C | C38H45N3O6 | 639.8 | |
Lithocholic-2,2,3,4,4-d5 Acid | 434-13-9 (non-d) | C24H35O3D5 | 381.61 |
Lithocholic-2,2,4,4-d4 Acid | 434-13-9 (non-d) | C24H36O3D4 | 380.61 |
Taurolithocholic-2,2,3,4,4-D5 Acid | C26H40NO5SD5 | 488.75 | |
Taurolithocholic-2,2,4,4-D4 Acid | C26H41NO5SD4 | 487.75 | |
Lasofoxifene | 180916-16-9 | C28H31NO2 | 413.56 |
Lasofoxifene-d4 | 180916-16-9 (non-d) | C28H27NO2D4 | 417.59 |
Lasofoxifene glucuronide | C34H39NO8 | 589.69 | |
rac-Lasofoxifene-d5 | C28H26NO2D5 | 418.59 | |
Lamivudine-13C-d2 | 134678-17-4 | C8H9N3O3SD2 | 232.26 |
Lamivudine-13C-15N2 | C8H11N3O3S | 232.23 | |
Lamivudine | 134678-17-4 | C8H11N3O3S | 229.26 |
Lamivudine Impurity B | C8H11N3O3S | 229.26 | |
Lamivudine acid | C8H9N3O4S | 243.24 | |
5'-Epi Lamivudine | 139757-68-9 | C8H11N3O3S | 229.26 |
Lamivudine S-oxide | C8H11N3O4S | 245.26 | |
Lubiprostone | 333963-40-9 | C20H32F2O5 | 390.47 |
Lubiprostone-d4 | 333963-40-9 (non-d) | C20H28F2O5D4 | 394.5 |
15-Hydroxy lubiprostone-mixture of isomers | C20H34F2O5 | 392.49 | |
15-Hydroxy lubiprostone-d4 | C20H30F2O5D4 | 396.51 | |
Lubiprostone | 136790-76-6 | C20H32F2O5 | 390.47 |
Lubiprostone-d7 | 333963-40-9 (non-d) | C20H25F2O5D7 | 397.51 |
Lubiprostone related compound 1 | C20H32F2O5 | 390.47 | |
Lubiprostone related compound 2 | C20H32F2O5 | 390.47 | |
Levonorgestrel Sulfate Sodium Salt | C21H27O5S.Na | 391.51 22.99 | |
Levonorgestrel Impurity P | 100021-05-4 | C21H28O2 | 312.46 |
Levonorgestrel Impurity C | C23H28O | 320.48 | |
Levonorgestrel Impurity M | 51087-61-7 | C21H26O2 | 310.44 |
Aromatic levonorgestrel | C22H28O2 | 324.47 | |
Delta1 (10)-4, 5-dihydro-levonorgestrel | C21H28O2 | 312.46 | |
Levonorgestrel Impurity A | 110785-09-6 | C21H26O2 | 310.44 |
Levonorgestrel Impurity S | N/A | C22H30O2 | 326.48 |
Levonorgestrel Impurity O | C22H32O3 | 344.5 | |
Levonorgestrel Impurity L (18-Methylester-4-ene-3,17-dione) | 21800-83-9 | C19H26O2 | 286.42 |
Levonorgestrel Impurity B | C21H28O2 | 312.46 | |
Levonorgestrel-d6 ((-)-Norgestrel-d6) | 793-67-7 (non-d) | C21H22O2D6 | 318.49 |
10-alpha-Hydroxy Levonorgestrel | C21H28O3 | 328.46 | |
Levonorgestrel Impurity V | C22H28O2 | 324.47 | |
Levonorgestrel Impurity W | C21H24O2 | 308.42 | |
Levonorgestrel Impurity R | 2322-77-2 | C20H28O2 | 300.44 |
Levonorgestrel Impurity Q | 1038-28-4 | C20H30O2 | 302.46 |
Levonorgestrel Impurity T | 799-43-9 | C22H30O2 | 326.48 |
Delta-5(10)-8-alfa-Levonorgestrel | N/A | C21H28O2 | 312.46 |
Levonorgestrel Impurity J (6-Keto Levonorgestrel) | 1175109-63-3 | C21H26O3 | 326.44 |
Levonorgestrel Impurity D | 32419-58-2 | C21H30O | 298.47 |
D-(-)-Norgestrel (Levonorgestrel) | 797-63-7 | C21H28O2 | 312.46 |
10-beta-Hydroxy Levonorgestrel | 21508-50-9 | C21H28O3 | 328.46 |
6-alfa-Hydroxy Levonorgestrel | C21H28O3 | 328.46 | |
Levonorgestrel Impurity H (6-beta-Hydroxy Levonorgestrel) | C21H28O3 | 328.46 | |
Levonorgestrel Impurity N | 4222-96-2 | C19H26O2 | 286.42 |
Levofloxacin | C18H20FN3O4 | 361.38 | |
Levofloxacin Related Compound C | C20H24FN3O4 | 389.43 | |
Levofloxacin-d8 | 1217716-71-6 | C18H12FN3O4D8 | 369.42 |
Levofloxacin Diformyl Impurity | 151377-74-1 | C18H18FN3O6 | 391.36 |
Levofloxacin N-oxide | 117678-38-3 | C18H20FN3O5 | 377.38 |
Levofloxacin-Acyl-D-Glucuronide | 160962-46-9 | C24H28FN3O10 | 537.5 |
9-Piperazine Levofloxacin Impurity | 178912-62-4 | C18H20FN3O4 | 361.38 |
Descarboxyl Levofloxacin | 178964-53-9 | C17H20FN3O2 | 317.37 |
Levofloxacin Tetrafluoro Impurity 1 | 110548-02-2 | C15H15F4NO4 | 349.28 |
Levofloxacin Tetrafluoro Impurity 2 | 103995-33-1 | C14H12F4O4 | 320.24 |
Levofloxacin Related Compound B | C13H9F2NO4 | 281.22 | |
N-Desmethyl Levofloxacin (Levofloxacin Related Compound A) | C18H20FN3O4 | 347.35 | |
N-Desmethyl Levofloxacin-d8 | C17H10FN3O4D8 | 1071-083A1 | |
Levofloxacin-13C-d3 | C17H17FN3O413CD3 | 365.38 | |
Defluoro Levofloxacin | 117620-85-6 | C18H21N3O4 | 343.39 |
N,N̢۪-Desethylene Levofloxacin | C16H19N3O4 | 317.35 | |
Levofloxacin Diamine | C15H16FN3O4 | 321.31 | |
(R)-Levofloxacin | C18H20FN3O4 | 361.38 | |
Lomerizine diHCl | C27H30F2N2O3.2 HCl | 468.55 2 36.46 | |
Lomerizine-d8 diHCl | C27H22F2N2O3D8.2 HCl | 476.60 2 36.46 | |
Lapatinib | 231277-92-2 | C29H26ClFN4O4S | 581.07 |
Lapatinib Impurity 9 | N/A | C26H17ClFN3O3 | 473.9 |
Lapatinib Impurity 10 | 1152131-73-1 | C26H17ClFN3O4 | 489.89 |
Lapatinib 4-Fluoro Impurity | N/A | C29H26ClFN4O4S | 581.07 |
Lapatinib 2-Fluoro Impurity | N/A | C29H26ClFN4O4S | 581.07 |
Lapatinib Hydroxylamine | C29H26ClFN4O5S | 597.07 | |
Lapatinib-d5 | C29H21ClFN4O4SD5 | 586.1 | |
Lapatinib-d4 Ditosylate | 388082-78-8 (non-labelled) | C29H22ClFN4O4SD4 2C7H8O3S | 585.09 2 172.20 |
O-De(3-fluorobenzyl) Lapatinib Ditosylate Salt | C22H21ClN4O4S . 2 C7H8O3S | 472.95 2 172.20 | |
Lapatinib Ditosylate | 388082-77-7 | C29H26ClFN4O4S. 2 C7H8O3S | 581.07 2 172.20 |
Lapatinib Impurity 1 | 1268997-70-1 | C22H21ClN4O4S | 472.95 |
Lapatinib Impurity 2 | N/A | C29H24ClFN4O4S | 579.05 |
Lapatinib Impurity 3 | N/A | C26H20ClFN4O2 | 474.93 |
Lapatinib Impurity 8 | N/A | C26H19ClFN3O3 | 475.91 |
Lenalidomide | 191732-72-6 | C13H13N3O3 | 259.27 |
Lenalidomide-d5 | 191732-72-6 (non-d) | C13H8N3O3D5 | 264.35 |
Lumiracoxib-acyl-β-D-glucuronide | C21H21Cl2NO8 | 486.31 | |
Lumiracoxib | 220991-20-8 | C15H13ClFNO2 | 293.73 |
Lacosamide | 175481-36-4 | C13H18N2O3 | 250.3 |
LAC2-IBCA | C16H24N2O4 | 308.38 | |
LAC2 NMBA Impurity | C14H20N2O3 | 264.33 | |
(S)-Lacosamide | C13H18N2O3 | 250.3 | |
(R)-O-Acetyl-Lacosamide | 1318777-54-6 | C14H18N2O4 | 278.31 |
Lacosamide-d3 | 175481-36-4 (non-d) | C13H15N2O3D3 | 253.36 |
Lacosamide-d3 | C13H15N2O3D3 | 253.32 | |
N-Desacetyl Lacosamide HCl | C11H16N2O2.HCl | 208.26 36.46 | |
Lacosamide-d6 | C13H12N2O3D6 | 256.34 | |
Benzylamine | 100-46-9 | C7H9N | 107.16 |
Desmethyl Lacosamide | 175481-38-6 | C12H16N2O3 | 236.27 |
O-Acetyl Lacosamide | N/A | C14H18N2O4 | 278.31 |
Desacetyl Desmethyl Lacosamide | N/A | C10H14N2O2 | 194.24 |
Lumenfantrine | 82186-77-4 | C30H32Cl3NO | 528.95 |
Lumenfantrine-d9 | 82186-77-4 (non-d) | C30H23Cl3NOD9 | 538.01 |
Lumenfantrine glucuronide (mixture of diasteromers) | C36H40Cl3NO7 | 705.08 | |
N-Desbutyl Lumefantrine | C26H24Cl3NO | 472.85 | |
Lumenfantrine Impurity A | NA | C30H32Cl3NO | 528.95 |
Keto Impurity | NA | C23H27Cl2NO2 | 420.38 |
2-(2,7-Dichloro-9H-fluoren-4-yl)oxirane | N/A | C15H10Cl2O | 277.15 |
2-(Dibutylamino)-1-(2,7-dichloro-9H-fluoren-4-yl)ethanol | N/A | C23H29Cl2NO | 406.4 |
Lopinavir | C37H48N4O5 | 628.82 | |
Lopinavir-d8 | C37H40N4O5D8 | 636.87 | |
Lopinavir Impurity S | N/A | C47H58N4O7 | 791.01 |
Lopinavir Impurity T | N/A | C57H66N4O7 | 919.18 |
Lopinavir Metabolite M1 | 192725-39-6 | C37H46N4O6 | 642.8 |
Lopinavir Metabolite M3-M4 | 357275-54-8 | C37H48N4O6 | 644.82 |
Lopinavir Impurity R | C47H58N4O7 | 791.01 | |
4-Oxo Lopinavir | C37H46N4O5 | 626.8 | |
12-Hydroxy Lauric Acid-d20 | 505-95-3 (non-d) | C12H4O3D20 | 236.44 |
12-Hydroxy Lauric Acid | C12H24O3 | 216.32 | |
Latanoprost | 130209-82-4 | C26H40O5 | 432.61 |
15-Keto Latanoprost Acid | C23H32O5 | 388.51 | |
Latanoprost Impurity (Diphenylphosphine Isopropyl Ester) | N/A | C20H25O3P | 344.39 |
9-Acetyl Latanoprost | N/A | C28H42O6 | 474.64 |
Tafluprost | 209860-87-7 | C25H34F2O5 | 452.54 |
Tafluprost acid | 209860-88-8 | C22H28F2O5 | 410.46 |
15(S)-Latanoprost | 145773-22-4 | C26H40O5 | 432.61 |
5-trans-Latanoprost | C26H40O5 | 432.6 | |
15-Keto Latanoprost | C26H38O5 | 430.59 | |
5,6-trans-Latanoprost (50.0 mg in 5.0 ml methyl acetate) | C26H40O5 | 432.61 | |
trans (15S)-Latanoprost | trans (15S)-Latanoprost | C26H40O5 | 432.61 |
Latanoprost acid | 41639-83-2 | C23H34O5 | 390.52 |
15(R)-trans-Latanoprost (10.0 mg in 1.0 ml methyl acetate) | C26H40O5 | 432.61 | |
Latanoprost Epoxide (mixture of isomers) | C26H40O6 | 448.61 | |
Lupeol | C30H50O | 426.73 | |
Levosulpiride | 23672-07-3 | C15H23N3O4S | 341.43 |
Levosulpiride-d3 | C15H20D3N3O4S | 344.44 | |
Lornoxicam | 70374-39-9 | C13H10ClN3O4S2 | 371.82 |
Lornoxicam Impurity 9 | 70374-36-6 | C5H4ClNO4S2 | 241.67 |
Lornoxicam Impurity 1 | C12H8ClN3O6S3 | 421.86 | |
Lornoxicam Impurity 2 | C12H10ClN3O5S3 | 407.88 | |
Lornoxicam Impurity 3 | N/A | C5H3ClO4S2 | 226.66 |
Lornoxicam Impurity 4 | N/A | C9H12ClNO6S2 | 329.78 |
Lornoxicam Impurity 5 | N/A | C9H13ClN2O5S2 | 328.8 |
Lornoxicam Impurity 6 | C6H5ClO4S2 | 240.69 | |
Lornoxicam Impurity 7 | C7H6N2O3 | 166.14 | |
Lornoxicam Impurity 8 | 187746-94-7 | C5H3ClO5S2 | 242.66 |
Luliconazole | 187164-19-8 | Luliconazole | 354.28 |
(R)-(Z)-Luliconazole Isomer | C14H9Cl2N3S2 | 354.28 | |
(S)-(E)-Luliconazole Isomer | 256424-63-2 | C14H9Cl2N3S2 | 354.28 |
Luliconazole Z-Isomer | C14H9Cl2N3S2 | 354.28 | |
Laropiprant | 571170-77-9 | C21H19ClFNO4S | 435.91 |
Laropiprant-d4 | 1132664-22-2 | C21H15ClFNO4SD4 | 439.96 |
R-Laropiprant | C21H19ClFNO4S | 435.91 | |
S-Laropiprant | C21H19ClFNO4S | 435.91 | |
Levomefolate-d4 | C20H21N7O6D4 | 463.49 | |
Levomefolate | C20H25N7O6 | 459.47 | |
L-382 | |||
Levomefolate-d5 | C20H20N7O6D5 | 464.5 | |
Levomefolate-13C-d3 | C20H22N7O6D3 | 463.47 | |
Calcium Levomefolate (L-5-Methyltetrahydrofolate Calcium Salt.5H2O) | C20H23N7O6.Ca.5 H2O | 457.45 40.08 5 18.02 | |
Loteprednol | 129260-79-3 | C21H27ClO5 | 394.9 |
Loteprednol Etabonate | 82034-46-6 | C24H31ClO7 | 466.96 |
Loteprednol Etabonate-d3 | C24H28ClO7D3 | 469.98 | |
Loteprednol Etabonate-d5 | 82034-46-6 (non-labelled) | C24H26ClO7D5 | 471.99 |
Leuprolide Acetate (Leuprorelin Acetate) | 74381-53-6 | C59H84N16O12.C2H4O2 | 1269.48 |
Leuprolide-d5 | C59H79N16O12D5 | 1214.46 | |
Levosimendan | 141505-33-1 | C14H12N6O | 280.29 |
Levosimendan Impurity (2-[2-[4-(2-Azidotetrahydro-3-Methyl-5-oxo-2-Furanyl)phenyl]hydrazinylidene]propanedinitrile) | 252638-01-0 | C14H11N7O2 | 309.29 |
Levosimendan Impurity 1 | C22H23N7O2 | 417.47 | |
Levosimendan Impurity 2 | C16H17N5O3 | 327.35 | |
Levosimendan Impurity 3 | C30H30N12O3 | 606.65 | |
Linagliptin | 668270-12-0 | C25H28N8O2 | 472.55 |
Linagliptin Impurity D | C20H18N6O3 | 390.4 | |
Linagliptin Impurity F | C19H26N4O2 | 342.44 | |
Linagliptin Impurity G | C36H40N10O4 | 676.78 | |
Linagliptin Impurity N | C31H32N10O2 | 576.67 | |
Linagliptin Impurity M | C15H20N4 | 256.35 | |
Linagliptin Impurity S | C25H29BrN8O2 | 553.47 | |
Linagliptin-d3 | N/A | C25H25N8O2D3 | 475.57 |
Linagliptin Diene Impurity | N/A | C25H28N8O2 | 472.55 |
Linagliptin Dimer Impurity | N/A | C52H59N17O4 | 986.16 |
Linagliptin Dimer Impurity 2 | C50H56N16O4 | 945.11 | |
Linagliptin Phthalimide Impurity | C33H32N8O4 | 604.67 | |
Linagliptin Dimer Impurity 3 | C52H60N16O4 | 973.16 | |
Linagliptin Metabolite CD1790 | C25H27N7O3 | 473.54 | |
Linagliptin Impurity B | C26H21BrN8O2 | 557.41 | |
Levomedetomidine HCl | 119717-21-4 | C13H17N2Cl | 236.75 |
Levomedetomidine | C13H16N2 | 200.29 | |
Levothyroxine-13C6 | C15H11I4NO4 | 782.81 | |
Levothyroxine acyl glucuronide | C21H19I4NO10 | 953 | |
Levothyroxine phenolic glucuronide | C21H19I4NO10 | 953 | |
Levothyroxine sulfate | C15H11I4NO7S | 856.94 | |
O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-hydroxy-l-tyrosine | C15H11I4NO5 | 792.88 | |
2-Hydroxy-2-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)acetic acid | C14H8I4O5 | 763.83 | |
N-Formyl-O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-l-tyrosine | C16H11I4NO5 | 804.89 | |
2-(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)acetamide | C14H9I4NO3 | 746.85 | |
N-Acetyl-O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-l-tyrosine | C17H13I4NO5 | 818.91 | |
2-(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)acetic acid | C14H8I4O4 | 747.84 | |
4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodobenzaldehyde | C13H6I4O3 | 717.81 | |
4-(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodobenzoic acid | C13H6I4O4 | 733.81 | |
O-(4-Hydroxy-3,5-Diiodophenyl)-3,5-Diiodo-beta-Hydroxy-L-Tyrosine | N/A | C15H11I4NO5 | 792,88 |
(S)-2-Amino-3-[4-[4-(4-Hydroxy-3,5-Diiodophenoxy)-3,5-Diiodophenoxy]- 3,5-Diiodophenyl]propanoic Acid | N/A | C21H13I6NO5 | 1120.77 |
Levothyroxine N-Methylamine | C16H14I4N2O3 | 789.92 | |
Levothyroxine N-methylamide | C16H14I4N2O3 | 789.92 | |
3,5-Diiodo-L-tyrosine | C9H9I2NO3 | 432.99 | |
Levothyroxine Related Compound (2-Acetamido-3-(4-acetoxy-3,5-diiodophenyl)propanoic Acid) | 153324-21-1 | C13H13I2NO5 | 517.06 |
Levothyroxine Related Compound (N-Acetyl-3,5-Diiodo-L-Tyrosine) | 1027-28-7 | C11H11I2NO4 | 475.02 |
Levothyroxine Related Compound (N-Acetyl 3,5-diiodo-L-tyrosine Methyl Ester) | 56460-41-4 | C12H13I2NO4 | 489.05 |
Bis(p-anisyl)iodonium bromide | C14H14IO2.Br | 341.17 79.90 | |
Levothyroxine Related Compound (2-Acetamido-3-(3,5-diiodo-4-(4-methoxyphenoxy)phenyl) Propanoic Acid) | 886203-79-8 | C18H17I2NO5 | 581.15 |
2-Amino-3(3-bromo-4-(4-hydroxyphenoxy)-5-iodophenyl)propanoic acid | C15H13BrINO4 | 478.08 | |
Levothyroxine Related Compound (2-Amino-3-(3,5-diiodo-4-(4-methoxyphenoxy)phenyl)propanoic acid) | 94345-95-6 | C16H15I2NO4 | 539.11 |
Levothyroxine Related Compound (Methyl 2-acetamido-3-(3,5-diiodo-4-(4-methoxyphenoxy)phenyl) Propanoate) | C19H19I2NO5 | 595.18 | |
Lafutidine | 118288-08-7 | C22H29N3O4S | 431.56 |
Lafutidine Impurity A | C6H5NO3 | 139.11 | |
Lafutidine Impurity B | C22H29N3O5S | 447.56 | |
Lafutidine Impurity C | C15H23N3O | 261.37 | |
Lafutidine Impurity D | C22H31N3O5S | 449.57 | |
Lafutidine-d10 | C22H19N3O4SD10 | 441.62 | |
Lafutidine Dihydro Impurity | N/A | C22H31N3O4S | 433.57 |
Labetalol | 36894-69-6 | C19H24N2O3 | 328.41 |
Labetalol Impurity A | N/A | C19H23NO4 | 329.4 |
Labetalol Impurity B | N/A | C19H25NO4 | 343.43 |
Labetalol-d6 | C19H18N2O3D6 | 334.45 | |
Labetalol-d5 HCl | C19H19N2O3D5. HCl | 333.44 36.46 | |
Labetalol Impurity C | 30566-92-8 | C23H22N2O3 | 374.44 |
Labetalol Impurity D | C19H30N2O3 | 334.46 | |
Lobucavir | C11H15N5O3 | 265.27 | |
R-Lipoic Acid Impurity 2 (S-Oxide) | 188783-96-2 | C8H14O3S2 | 222.33 |
rac-Lipoic Acid-d5 | C8H9O2S2D5 | 211.36 | |
1,2,3-Trithiane-4-Pentanoic Acid (Thioctic Acid Impurity A) | 1204245-29-3 | C8H14O2S3 | 238.39 |
Lipoic Acid Related Compound | 916746-61-7 | C12H23NO4S2 | 309.45 |
Dihydrolipoic Acid | 462-20-4 | C8H16O2S2 | 208.34 |
rac-Lipoic Acid Impurity 1 (S-Oxide) | 108015-78-7 | C8H14O3S2 | 222.33 |
rac-Lipoic Acid Impurity 2 (S-Oxide) | 6992-30-9 | C8H14O3S2 | 222.33 |
rac-Lipoic Acid Impurity 3 (S-Oxide) | 17370-41-1 | C8H14O4S2 | 238.33 |
R-Lipoic Acid Impurity 1 (S-Oxide) | 188745-24-6 | C8H14O3S2 | 222.33 |
Levocarnitine Impurity B | C10H16O4 | 200.24 | |
Levocarnitine Impurity C | C7H17N2O2 . Cl | 161.23 35.45 | |
Levocarnitine Impurity D | C7H15N2O | 143.21 | |
Lipstatin | 96829-59-3 | C29H49NO5 | 491.72 |
Lipstatin-d3 | C29H46NO5D3 | 494.74 | |
Linoleoyl Carnitine | 36816-10-1 | C25H49NO4 | 427.67 |
Loxoprofen | 68767-14-6 | C15H18O3 | 246.31 |
Loxoprofen Ring-opening Impurity | 1091621-61-2 | C15H18O5 | 278.31 |
Loxoprofen related compound 1 | C25H36O3 | 384.56 | |
Loxoprofen related compound 2 | C15H18O4 | 262.31 | |
Levamisole Phosphate | 32093-35-9 | C11H12N2S. H3O4P | 204.30 98.00 |
Linolenic Acid | 463-40-1 | C18H30O2 | 278.44 |
Lycoramine | 21133-52-8 | C17H23NO3 | 289.38 |
Mefenamic acid-d4 | 61-68-7 | C15H11D4NO2 | 245.32 |
Mefenamic Acid Impurity D (Benzoic Acid) | 65-85-0 | C7H6O2 | 122.12 |
Mefenamic acid-acyl-â-D-glucuronide | 102623-18-7 | C21H23NO8 | 417.42 |
Mefenamic acid-d3 | C15H12NO2D3 | 244.31 | |
4-hydroxy Mefenamic acid-d3 | C15H12NO3D3 | 260.31 | |
Mefenamic Acid | 61-68-7 | C15H15NO2 | 241.29 |
Mefenamic Acid Impurity B | C23H24N2O | 344.46 | |
Mefenamic Acid Impurity E | 08-11-4869 | C14H15N | 197.28 |
Mefenamic Acid Impurity A | N/A | C8H11N | 121.18 |
Mefenamic Acid Impurity C | N/A | C7H5ClO2 | 156.57 |
Meloxicam | 71125-38-7 | C14H13N3O4S2 | 351.41 |
Meloxicam Impurity (CDBC98SE) | 632-25-7 | C7H6O5S | 202.19 |
Meloxicam Impurity (CDBC96SE) | C8H9NO4S | 215.23 | |
Meloxicam Impurity C | C15H15N3O4S2 | 365.43 | |
Meloxicam Impurity E | C11H11NO5S | 269.28 | |
Meloxicam-d3 | 71125-38-7 | C14H10D3N3O4S2 | 354.42 |
5'-Carboxy Meloxicam | NULL | C14H11N3O6S2 | 381.39 |
5'-Hydroxy Meloxicam | NULL | C14H13N3O5S2 | 367.4 |
Meloxicam Related Compound A | NA | C12H13NO5S | 283.31 |
Meloxicam Related Compound B | NA | C4H6N2O | 98.11 |
Meloxicam EP Impurity F (Meloxicam USP Related Compound C) | 118854-48-1 | C13H15NO5S | 297.33 |
Meloxicam Related Compound D | NA | C15H15N3O4S2 | 365.43 |
Meloxicam Impurity D | C16H17N3O4S2 | 379.46 | |
Meperidine-d4 | 53484-73-4 | C15H17D4NO2 | 251.3 |
4-Hydroxy mephenytoin | 61837-65-8 | C12H11D3N2O3 | 234.26 |
4-Hydroxy Mephenytoin-d3 | 61837-65-8(non-d) | C12H11D3N2O3 | 237.28 |
N-Desmethyl Mephenytoin-d5 | C11H7D5N2O2 | 209.26 | |
(S)-4-Hydroxy Mephenytoin | C12H14N2O3 | 234.26 | |
(S)-(+)-Mephenytoin | 70989-04-7 | C12H14N2O2 | 218.26 |
Metaxalone | 1665-48-1 | C12H15NO3 | 221.26 |
Metaxalone-d6 | 1665-48-1(non-d) | C12H9D6NO3 | 227.29 |
Metaxalone Impurity A (3-(3, 5-Dimethylphenoxyl)-Propane-1, 2-Diol) | 59365-66-1 | C11H16O3 | 196.25 |
Metaxalone Related Compound A | C12H16N2O2 | 220.27 | |
Methoxsalen-d3 | 298-81-7 | C12H5D3O4 | 217.24 |
Methoxsalen | 298-81-7 | C12H8O4 | 216.2 |
alpha-Hydroxy Metoprolol | 56392-16-6 | C15H25NO4 | 283.37 |
Metoprolol Impurity B | C9H12O2 | 152.19 | |
Metoprolol Impurity F | C11H17NO2 | 195.26 | |
Metoprolol Impurity H | C14H23NO3 | 253.34 | |
Metoprolol Impurity I | 933468-54-3 | C14H21NO2 | 235.33 |
Metoprolol Hemitartrate | 56392-17-7 | C15H25NO3. 0.5 C4H6O6 | 267.37 0.5 150.09 |
(S)-(-)-Metoprolol | 81024-42-2 | C15H25NO3 | 267.37 |
(R)-(+)-Metoprolol | 81024-43-3 | C15H25NO3 | 267.37 |
Metoprolol-d6 Tartrate | C15H19NO3D6.0.5C4H6O6 | 273.41 75.05 | |
Metoprolol Impurity J | C18H31NO5 | 341.45 | |
Metoprolol Impurity A | C14H23NO3 | 253.34 | |
Maprotiline HCl | 10347-81-6 | C20H23N. HCl | 277.41 36.46 |
Maprotiline-d3 HCl | 1329496-63-0 | C20H20ND3. HCl | 280.43 36.46 |
N-Desmethyl Maprotiline HCl | 92202-51-2 | C19H21N. HCl | 263.39 36.46 |
Maprotiline Impurity E (N-Methyl Maprotiline) | 23941-38-0 | C21H25N | 291.44 |
Metoprolol Impurity E | C15H25NO3 | 267.37 | |
Macamide Impurity 1 | C23H39NO | 345.57 | |
Macamide Impurity 2 | C25H41NO | 371.61 | |
Macamide Impurity 3 | C25H39NO | 369.6 | |
Macamide Impurity 5 | C24H41NO2 | 375.6 | |
Macamide Impurity 9 | C26H43NO2 | 401.64 | |
Macamide Impurity 10 | C26H41NO2 | 399.62 | |
Metoprolol Impurity D | C12H18O4 | C12H18O4 | |
Mitoxantrone Impurity B | C22H28N4O5 | 428.49 | |
Mitoxantrone Impurity C | C22H27ClN4O6 | 478.94 | |
Mitoxantrone Impurity A | 89991-52-6 | C18H19N3O5 | 357.37 |
Mitoxantrone Impurity D | 137132-70-8 | C22H26N4O6 | 442.48 |
Metoprolol Impurity C | C12H18ClNO3 | 259.73 | |
N-Desmethyl mianserin | 57257-81-5 | C17H18N2 | 250.35 |
Mitotane-d4 | C14H6Cl4D4 | 324.07 | |
Mitotane | 53-19-0 | C14H10Cl4 | 320.05 |
8-Hydroxy mianserin | 102335-57-9 | C17H18N2 | 280.37 |
Methicillin Sodium | 132-92-3 | C17H19N2O6S Na | 379.41 22.99 |
Mianserin-d3 HCl | C18H17N2D3.HCl | 267.39 36.46 | |
Minodronic Acid | 155648-60-5 | C9H12N2O7P2 | 322.15 |
Minodronic Acid-d4 | N/A | C9H8N2O7P2D4 | 326.18 |
Minodronic Acid Related Compound | 21755-34-0 | C11H12N2O2 | 204.23 |
Mianserin HCl | C18H20N2 . HCl | 264.37 36.46 | |
Menthol-d4 | N/A | C10H16OD4 | 160.29 |
2-(4,6-Diamino-1,3,5-triazin-2-yl)sulfanylethanesulfonic Acid | C5H9N5O3S2 | 251.29 | |
2-[[(Guanidino)(imino)methyl]sulfanyl]ethanesulfonic Acid | C4H10N4O3S2 | 226.28 | |
2-(2-Sulfoethyl)pseudourea | 25985-57-3 | C3H8N2O3S2 | 184.24 |
3-Hydroxy Mepivacaine | 37055-90-6 | C15H22N2O2 | 262.35 |
Mepivacaine Impurity D | C15H20N2O | 244.34 | |
Mepivacaine Impurity E | C15H21ClN2O | 280.8 | |
Melperone-d4 HCl | 1622-79-3 (non-labelled) | C16H18FNOD4. HCl | 267.38 36.46 |
Melperone HCl | 1622-79-3 | C16H22FNO. HCl | 263.36 36.46 |
MTSL (S-(2,2,5,5-Tetramethyl-2,5-Dihydro-1H-Pyrrol-3yl)methyl Methanesulfonothioate | 81213-52-7 | C10H18NO3S2 | 264.39 |
Methiocarb sulfoxide-d3 | C11H12NO3SD3 | 244.33 | |
Mirtazapine-d4 HCl | 61337-67-5 (non-d) | C17H15D4N3.HCl | 305.82 |
Mirtazapine Impurity C | N/A | C17H17N3O | 279.34 |
Moroxydine Hydrochloride | 3160-91-6 | C6H13N5O . HCl | 171.20 36.46 |
Mirtazapine Impurity F (10-oxo mirtazapine) | 191546-97-1 | C17H17N3O | 279.34 |
Mirtazapine | 85650-52-8 | C17H19N3 | 265.36 |
Mirtazapine Carbonitrile Impurity | 61337-88-0 | C17H18N4 | 278.36 |
Mirtazapine N-Glucuronide | N/A | C23H27N3O6 | 441.49 |
Mirtazapine Impurity A (Desmethyl mirtazapine HCl) | C16H17N3.HCl | 287.79 | |
Meclozine | 569-65-3 | C25H27ClN2 | 390.96 |
Meclozine EP Impurity B (4-Chlorobenzhydrol) | 119-56-2 | C13H11ClO | 218.69 |
Desmethyl mirtazapine-d4 HCl | NULL | C16H13D4N3.HCl | 291.79 |
Moclobemide | 71320-77-9 | C13H17ClN2O2 | 268.75 |
Moclobemide-N-Oxide | C13H17ClN2O3 | 284.75 | |
Molclobemide-d4 | C13H13ClN2O2D4 | 272.77 | |
Moclobemide morpholine C-oxidized derivative | C13H15ClN2O2 | 266.73 | |
8-Hydroxy mirtazapine | 102335-57-9 | C17H19N3O | 281.36 |
Myristamidopropyl Dimethylamine | 45267-19-4 | C19H40N2O | 312.54 |
8-Hydroxy mirtazapine-d4 | 102335-57-9(non-d) | C17H15D4N3O | 285.38 |
Methacrylic Acid | 79-41-4 | C4H6O2 | 86.09 |
Mirtazapine-13C-d3 HCl | C1613CH16N3D3.HCl | 269.37 36.46 | |
Meptazinol | 54340-58-8 | C15H23NO | 233.36 |
Meptazinol Hydrochloride | 59263-76-2 | C15H23NO.HCl | 233.36 36.5 |
Meptazinol-13CD3 | C15H20NOD3 | 237.36 | |
Meptazinol impurity A | C15H21NO2 | 247.34 | |
Meptazinol impurity B | C15H23N | 217.36 | |
Meptazinol impurity C | C30H44N2O | 448.7 | |
Meptazinol impurity D | C30H44N2O | 448.7 | |
Meptazinol impurity E | C19H31NO | 289.47 | |
Mirtazapine-d4 | 85650-52-8 (non-labelled) | C17H15D4N3 | 269.39 |
Miglustat | 72599-27-0 | C10H21NO4 | 219.28 |
Miglustat-D9 | C10H12NO4D9 | 228.34 | |
Mirtazapine Impurity E | C17H21N3 | 267.38 | |
Miriplatin Impurity | N/A | C34H68N2O6Pt2 | 991.11 |
Mirtazapine Impurity B | N/A | C17H19N3O H2O | 281.36 18.02 |
N-Ethyl-beta-Methylphenethylamine | 91339-15-0 | C11H17N | 163.26 |
N, N-Dimethyl-beta-Methylphenethylamine | 7560-81-8 | C11H17N | 163.26 |
N-Methyl-beta-Methylphenethylamine | 93-88-9 | C10H15N | 149.24 |
Myricetin | 529-44-2 | C15H10O8 | 318.24 |
Myricetin impurity 1 | C15H10O7 | 302.24 | |
Midodrine-d6 HCl | 3092-17-9 (non-d) | C12H12D6N2O4.HCl | 296.78 |
Bis(2-Ethylhexyl)-Maleate | 142-16-5 | C20H36O4 | 340.51 |
Midodrine Related Compound A (Desglymidodrine) | 3600-87-1 | C10H15NO3 | 197.24 |
delta-D-Mannonolactone | 32746-79-5 | C6H10O6 | 178.14 |
Maxacalcitol | 103909-75-7 | C26H42O4 | 418.62 |
Maxacalcitol 9-Hydroxy Iso Form | C26H42O4 | 418.62 | |
Maxacalcitol Impurity B | 132071-85-3 | C26H42O4 | 418.62 |
Maxacalcitol Preform | C26H42O4 | 418.62 | |
Methomyl | 16752-77-5 | C5H10N2O2S | 162.21 |
Mexiletine-D6 Hydrochloride | C11H11NOD6.HCl | 185.30 36.46 | |
Maytansine | 35845-53-8 | C34H46ClN3O10 | 692.21 |
Maytansinoid DM4 | C38H54ClN3O10S | 780.39 | |
Megastigmatrienone (Tabanone) | 13215-88-8 | C13H18O | 190.29 |
Mepartricin | 11121-32-7 | C59H86N2O19 | 1127.35 |
S(OH), R-Metconazole ((-)-cis-5-[(4-chlorophenyl)methyl]-2,2-dimethyl-1-(1H-1,2,4-triazole-1-ylmethyl]cyclopentanol) | C17H22ClN3O | 319.84 | |
R(OH), S-Metconazole ((1R,5S)-5-[(4-chlorophenyl)methyl]-2,2-dimethyl-1-(1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol) | C17H22ClN3O | 319.84 | |
Minoxidil-d10 | 38304-91-5 (non-labelled) | C9H5D10N5O | 219.31 |
Minoxidil-d10 sulfate | 83701-22-8(non-d) | C9H5D10N5O4S | 299.37 |
Minoxidil glucuronide | 56828-40-1 | C15H23N5O7 | 385.38 |
Minoxidil Sulphate | C9H15N5O.H2O4S | 209.25 98.08 | |
Desoxyminoxidil | 24867-26-3 | C8H13N5 | 179.23 |
Minoxidil Impurity A | C4H5ClN4O | 160.56 | |
Minoxidil Impurity B | C4H5ClN4 | 144.56 | |
Minoxidil Impurity C | C9H14N4O | 194.24 | |
Minoxidil Impurity D | 75105-16-7 | C11H12N4O4S | 296.31 |
Mometasone furoate-d3 | 83919-23-7 | C27H27D3Cl2O6 | 524.46 |
Mometasone Furoate Impurity E | N/A | C32H32Cl2O8 | 615.51 |
Mometasone Furoate Impurity F | 1305334-30-8 | C27H28Cl2O7 | 535.43 |
Mometasone Furoate Impurity I | N/A | C29H34Cl2O8 | 581.5 |
Mometasone-d6 | C22H22Cl2O4D6 | 433.41 | |
Mometasone-17, 20-Difuroate | N/A | C32H32Cl2O8 | 615.51 |
Mometasone Furoate Impurity 1 | C26H29ClO7 | 488.97 | |
Mometasone (Mometasone Furoate Impurity G) | 105102-22-5 | C22H28Cl2O4 | 427.37 |
Mometasone Furoate | C27H30Cl2O6 | 521.44 | |
Mometasone Furoate Impurity C | N/A | C27H29ClO6 | 484.98 |
Mometasone Furoate Impurity D | 83881-09-8 | C27H29ClO6 | 484.98 |
Mometasone Furoate Impurity H | N/A | C27H31ClO7 | 503 |
Mometasone Furoate Impurity A | 83880-65-3 | C27H29ClO5 | 468.98 |
Mometasone Furoate Impurity B | N/A | C28H31ClO8S | 563.07 |
Methotrimeprazine-d3 | NULL | C19H21N2OSD3 | 331.5 |
Methotrimeprazine Sulfoxide | NULL | C19H24N2O2S | 344.48 |
Mycophenolic Acid Phenyl Glucuronide | C23H28O12 | 496.47 | |
Mycophenolic Acid-13C-d3 | N/A | C17H17O6D3 | 324.35 |
(4Z)-Mycophenolate mofetil | C23H31NO7 | 433.51 | |
Mycophenolate Impurity B | C29H42N2O9 | 562.67 | |
Mycophenolate Impurity D | C24H33NO7 | 447.53 | |
Mycophenolic Acid-d3-Beta-D-Glucuronide | 31528-44-6 (non-labelled) | C23H25O12D3 | 499.49 |
Mycophenolic Acid Cyclopropane Analogue | 125198-40-5 | C18H22O6 | 334.37 |
Dihydroxy Analogue of Mycophenolic Acid | 31858-65-8 | C16H18O6 | 306.32 |
Dimethoxy Analogue of Mycophenolic Acid | C18H22O6 | 334.37 | |
Vinyl Lactone Analogue of Mycophenolic Acid | C17H18O6 | 318.33 | |
Mycophenolate Mofetil Impurity A, O-Desmethyl impurity | 1322681-36-6 | C22H29O7 | 419.48 |
Mycophenolic acid glucuronide cyclopropane analogue | NULL | C24H30O12 | 510.5 |
Mycophenolic acid acyl glucoside | 344562-78-3 | C23H30O11 | 482.49 |
Mycophenolate Mofetil Impurity E | 31858-66-9 | C18H22O6 | 334.37 |
Mycophenolic Acid Related Compound 1 (5,7-Dihydroxy-4 methylphthhalide) | C9H8O4 | 180.16 | |
Mycophenolic acid | 24280-93-1 | C17H20O6 | 320.35 |
Mycophenolic acid-d3 | 24280-93-1 | C17H17O6D3 | 323.36 |
Mycophenolate mofetil | 115007-34-6 | C23H31NO7 | 433.51 |
Mycophenolate mofetil-d4 | 115007-34-6 (non-d) | C23H27D4NO7 | 437.51 |
Mycophenolic acid acyl glucuronide | C23H28O12 | 496.47 | |
Mycophenolic Acid Phenolic beta-D-Glucoside | 55533-52-3 | C23H30O11 | 482.49 |
Mycophenolate Sodium | C17H19O6. Na | 319.34 22.99 | |
N-Acetyl Mesalamine | 51-59-2 | C9H9NO4 | 195.18 |
Mesalamine Impurity | C8H7NO5 | 197.15 | |
Mesalamine Impurity J | 112725-89-0(non-HCl) | C7H8N2O3 . HCl | 168.15 36.46 |
2-Hydroxy-5-amino-N-(2-carboxy-4-aminophenyl)benzoic Acid | N/A | C14H12N2O5 | 288.26 |
Mesalamine Impurity C | 95-55-6 | C6H7NO | 109.13 |
Mesalamine Impurity F | 570-23-0 | C7H7NO3 | 153.14 |
Mesalamine Impurity G | 490-79-9 | C7H6O4 | 154.12 |
Mesalamine Impurity H | 69-72-7 | C7H6O3 | 138.12 |
Mesalamine Impurity L | 118-91-2 | C7H5ClO2 | 156.57 |
Mesalamine Impurity M | 2516-96-3 | C7H4ClNO4 | 201.57 |
Mesalamine Impurity P | N/A | C13H11NO6S | 309.3 |
N-Acetyl Mesalamine-d3 | 1309935-89-4 | C9H6NO4D3 | 198.19 |
Mesalamine | 89-57-6 | C7H7NO3 | 153.14 |
N-Formyl-5-aminosalicylic Acid | C8H7NO4 | 181.15 | |
Mesalamine Related Compound (N-Butyryl-5-Aminosalicylic Acid) | 93968-81-1 | C11H13NO4 | 223.23 |
N-D-Glucopyranosyl-5-aminosalicylic Acid | C13H17NO8 | 315.28 | |
N-Propionyl Mesalazine-d3 | C10H8NO4D3 | 212.22 | |
Mesalamine Impurity I | 13147-53-3 | C13H10N2O3 | 242.24 |
3,6-Dioxocyclohexa-1,4-diene-1-carboxylic Acid | C7H4O4 | 152.11 | |
5-Amino-2-((5-amino-2-hydroxybenzoyl)amino)benzoic Acid | C14H12N2O5 | 288.26 | |
5-Amino-2-((5-amino-2-hydroxybenzoyl)oxy)benzoic Acid | C14H12N2O5 | 288.26 | |
Mesalamine-d3 | 1309283-32-6 | C7H4NO3D3 | 156.16 |
N-Propionyl mesalamine | C10H11NO4 | 209.2 | |
N-Acetyl -4-aminosalicyclic Aci | C9H9NO4 | 195.18 | |
N-Acetyl-d3 Mesalamine | C9H6NO4D3 | 198.19 | |
5-(N-β-D-Glucopyranosylamino)acetylsalicylic acid | C15H19NO9 | 357.32 | |
Mesalamine Impurity | C8H7NO5 | 197.15 | |
Mesalamine-13C6 HCl | C7H7NO3 . HCl | 159.07 36.46 | |
Mupirocin Lithium | 73346-79-9 | C26H43O9.Li | 506.57 |
Mecoprop-d3 | 352431-15-3 | C10H8ClO3D3 | 217.67 |
Metolachlor-d6 | 51218-45-2 | C15H16ClNO2D6 | 289.83 |
Misoprostol acid | NULL | C21H36O5 | 368.52 |
Misoprostol acid-d5 | NULL | C21H31D5O5 | 373.52 |
8-epi-Misoprostol | N/A | C22H38O5 | 382.55 |
Misoprostol Impurity (A-Form) | N/A | C22H36O4 | 364.53 |
Misoprostol Impurity (B-Form) | N/A | C22H36O4 | 364.54 |
Misoprostol | C22H38O5 | 382.55 | |
R-Manidipine | NULL | C35H38N4O6 | 610.72 |
Manidipine DiHCl | 89226-75-5 | C35H38N4O6 . 2 HCl | 610.72 2 36.46 |
R-Manidipine-d4 | NULL | C35H34N4O6D4 | 614.74 |
S-Manidipine | NULL | C35H38N4O6 | 610.72 |
S-Manidipine-d4 | NULL | C35H34N4O6D4 | 614.74 |
Manidipine | C35H38N4O6 | 610.72 | |
Manidipine-d4 | C35H34N4O6D4 | 614.74 | |
Manidipine Benzylidene | 119128-13-1 | C12H11NO5 | 249.23 |
Manidipine Bis Analog | N/A | C53H58N6O6 | 875.09 |
Manidipine Crotonate DiHCl | N/A | C24H30N2O2. 2 HCl | 378.52 2 36.46 |
Moxifloxacin | 151096-09-2 | C21H24FN3O4 | 401.44 |
Moxifloxacin Impurity E (8-Hydroxy Moxifloxacin) | N/A | C20H22FN3O4 | 387.41 |
8-Ethoxy Moxifloxacin HCl | C22H26FN3O4 . HCl | 415.47 36.46 | |
6-Methoxy Moxifloxacin | C21H25N3O4 | 383.45 | |
Moxifloxacin Impurity | 172426-88-9 | C14H13N2O4 | 292.27 |
8-Desmethoxy-8-Fluoro Moxifloxacin | C20H21F2N3O3 | 389.41 | |
Moxifloxacin-R-isomer (ent-Moxifloxacin) | 268545-13-7 | C21H24FN3O4 | 401.44 |
Moxifloxacin Impurity | N/A | C22H26FN3O4 | 415.47 |
N-Methyl Moxifloxacin HCl | 354812-41-2 | C22H26FN3O4 HCl | 415.47 36.46 |
Mexifloxacin Boron Complex Impurity | N/A | C18H17BF2NO8 | 424.15 |
Moxifloxacin Impurity | C16H16FNO5 | 321.31 | |
Moxifloxacin-d4 HCl | 151096-09-2 (non-d) | C21H20FN3O4D4.HCl | 405.47 36.46 |
Moxifloxacin Related Compound (1-Cyclopropyl-6,7-Difluoro-8-Methoxy-4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid) | 112811-72-0 | C14H11F2NO4 | 295.24 |
8-Methoxy Quinolonic Ethyl Ester | C16H15F2NO4 | 323.3 | |
Moxifloxacin acyl sulfate | NULL | C21H24FN3O7S | 481.5 |
Moxifloxacin N-sulfate | NULL | C21H24FN3O7S | 481.5 |
Moxifloxacin acyl glucuronide | C27H32FN3O10 | 577.57 | |
6,8-Dimethoxy Moxifloxacin | C22H27N3O5 | 413.48 | |
8-Fluoro-6-Methoxy Moxifloxacin | C21H24FN3O4 | 401.44 | |
Moxifloxacin Hydroxy Quinoline Impurity | N/A | C13H9F2NO4 | 281.22 |
Bromomethlenediphosphonic Acid | 10596-21-1 | CH3BrO6P2 | 252.88 |
Difluoromethlenediphosphonic Acid | 10596-32-4 | CH2F2O6P2 | 209.97 |
Mifepristone | 84371-65-3 | C29H35NO2 | 429.61 |
Mifepristone-D6 | C29H29NO2D6 | 435.64 | |
N-Demethyl Mifepristone-D3 | C28H30NO2D3 | 418.6 | |
Mifepristone-d3 | 84371-65-3 (non-d) | C29H32NO2D3 | 432.63 |
N-Desmethyl Mifepristone | 104004-96-8 | C28H33NO2 | 415.58 |
N-Didesmethyl Mifepristone | 104004-92-4 | C27H31NO2 | 401.55 |
Hydroxy Mifepristone | 105012-15-5 | C29H35NO3 | 445.61 |
Hydroxy Mifepristone-d6 | C29H29NO3D6 | 451.64 | |
Mifepristone related compound | 84371-64-2 | C31H41NO4 | 491.68 |
11-ent-Mifepristone | C29H35NO2 | 429.61 | |
N, N-Didesmethyl Mifepristone-D4 | C27H27NO2D4 | 405.58 | |
Montelukast sodium | 151767-02-1 | C35H35ClNO3S.Na | 585.19 22.99 |
Montelukast R, S-Isomer | N/A | C41H46ClNO5S2 | 732.41 |
cis-Montelukast | 774538-96-4 | C35H36ClNO3S | 586.2 |
Montelukast Impurity I | C35H36ClNO4S | 602.2 | |
Montelukast Impurity H | 851755-56-1 | C34H32ClNO4S | 586.16 |
Montelukast Keto Carbinol Impurity | N/A | C34H32ClNO4S | 586.16 |
Montelukast S-Enantiomer Sodium Salt | C35H35ClNO3S.Na | 585.19 22.99 | |
Montelukast Methyl Ether | C36H38ClNO3S | 600.23 | |
Montelukast Sulfone | C35H36ClNO5S | 618.2 | |
Montelukast Dihydro Impurity | 142147-98-6 | C35H38ClNO3S | 588.22 |
Montelukast Cyclopropacetaneamide Impurity | 866923-63-9 | C35H37ClN2O2S | 585.21 |
Montelukast-d6 sodium | 151767-02-1 (non-d) | C35H29ClNO3SD6.Na | 591.25 22.99 |
Montelukast 1, 2-Diol | 186352-97-6 | C35H36ClNO4S | 602.2 |
Montelukast CN Impurity | N/A | C35H35ClN2OS | 567.2 |
Montelukust Keto Impurity | N/A | C28H24ClNO2 | 441.96 |
Montelukust Diol Impurity | N/A | C29H28ClNO2 | 458.01 |
Montelukast Sulfone N-Oxide | N/A | C35H35ClNO6S | 633.19 |
Montelukast sulfoxide sodium | NULL | C35H35ClNO4S.Na | 601.19 22.99 |
Montelukast-acyl-β-D-glucuronide | C42H46ClNO8S | 760.35 | |
Montelukast-d6 | C35H30ClNO3SD6 | 592.24 | |
Montelukast Methyl Ketone (Mok-3 Keto) | 937275-23-5 | C34H32ClNO3S | 570.16 |
Montelukast Sulfoxide (Mixtuture of Diastereomers) | C35H36ClNO4S | 602.2 | |
Montelukast Methylstyrene Impurity | 918972-54-0 | C35H34ClNO2S | 568.18 |
Montelukast R, R-Isomer | N/A | C41H46ClNO5S2 | 732.41 |
Moexipril | 103775-10-6 | C27H34N2O7 | 498.58 |
Moexipril-d5 | 103775-10-6 (non-d) | C27H29N2O7D5 | 503.61 |
Moexiprilat-d5 | NULL | C25H25N2O7D5 | 475.56 |
Moexiprilat | NULL | C25H30N2O7 | 470.53 |
Moexipril Acyl Glucuronide | NULL | C31H38N2O13 | 646.65 |
Mirodenafil | 862189-95-5 | C26H37N5O5S | 531.68 |
Mirodenafil-d7 | N/A | C26H30N5O5SD7 | 538.72 |
Modafinil | 68693-11-8 | C15H15NO2S | 273.36 |
Modafinil-d5 | 68693-11-8 (non-d) | C15H10NO2SD5 | 278.39 |
Modafinil acid | 63547-24-0 | C15H14O3S | 274.34 |
(R)-Modanifil acid | 112111-45-2 | C15H14O3S | 274.34 |
S-Modafinil | C15H15NO2S | 273.36 | |
R-Modafinil | C15H15NO2S | 273.36 | |
Modafinil Sulfone | 118779-53-6 | C15H15NO3S | 289.36 |
Modafinil-d5 Acid | C15H9O3SD5 | 279.37 | |
(R)-(-)-Modafinil-d5 Acid | C15H9O3SD5 | 279.37 | |
(S)-(+)-Modafinil-d5 Acid | C15H9O3SD5 | 279.37 | |
Minocycline-D6 | 10118-90-8 (non-d) | C23H21N3O7D6 | 463.52 |
(R)-(-)-Modafinil-d5 | C15H10NO2SD5 | 278.39 | |
(S)-(+)-Modafinil-d5 | C15H10NO2SD5 | 278.39 | |
(S)-(+)-Modafinil Acid | C15H16O3S | 274.34 | |
Modafinil-d5 Sulfone | C15H10NO3SD5 | 294.39 | |
Modafinil Acid Sulfone | C15H14O4S | 290.34 | |
Modafinil-d5 Acid Sulfone | C15H9O4SD5 | 295.37 | |
Modafinil Impurity A | C15H15NO3S | 289.36 | |
2-[( Diphenyl methyl)sulfinyl] acetic acid methyl ester | C16H16O3S | 288.37 | |
7-Ethylmethylamino Analogue | C24H29N3O7 | 471.51 | |
Minocycline impurity A (4-epi Minocycline) | C23H27N3O7 | 457.49 | |
Minocycline-13C-d3 | 10118-90-8 (non-d) | C23H24N3O7D3 | 461.49 |
Minocycline HCl | C23H27N3O7. HCl | 457.49 36.46 | |
Minocycline Dehydro Analogue | C23H25N3O7 | 455.47 | |
Imino Delta Minocycline | C23H28N4O6 | 456.5 | |
Minocycline Impurity B (Sancycline) | 808-26-4 | C21H22N2O7 | 414.42 |
Minocycline Impurity C (7-Monodemthylminocycline) | C22H25N3O7 | 443.46 | |
Minocycline Impurity D (7-Aminosancycline) | C21H23N3O7 | 429.43 | |
6-Methoxy-2-naphthylacetic acid (6-MNA) | C13H12O3 | 216.24 | |
6-Methoxy-2-naphthylacetic acid (6-MNA)-13C-d3 | C13H9O3D3 | 220.25 | |
6-Methoxy-2-naphthylacetic acid (6-MNA) sulfate | C13H12O6S | 296.3 | |
6-Methoxy-2-naphthylacetic acid (6-MNA) glucuronide | C19H20O9 | 392.37 | |
Metopimazine | 14008-44-7 | C22H27N3O3S2 | 445.61 |
Metopimazine-d6 | 14008-44-7 (non-d) | C22H21N3O3S2D6 | 451.64 |
Metopimazine acid | C22H26N2O4S2 | 446.59 | |
Metopimazine acid-d6 | C22H20N2O4S2D6 | 452.63 | |
Metopimazine Sulfoxide | 18181-99-2 | C22H27N3O4S2 | 461.61 |
6-Desmethyl Moxonidine (Moxonidine Impurity D) | C8H10ClN5O | 227.65 | |
Moxonidine | 75438-57-2 | C9H12ClN5O | 241.6 |
Moxonidine-d3 | 75438-57-2 (non-d) | C9H9ClN5OD3 | 244.72 |
Moxonidine-d4 | C9H8ClN5OD4 | 245.71 | |
Moxonidine Impurity B | 75439-01-9 | C10H15N5O2 | 237.26 |
Moxonidine Impurity C (4-Hydroxymoxonidine) | C9H13N5O2 | 223.24 | |
Memantine HCl | C12H21N.HCl | 179.31 36.46 | |
Memantine Impurity C | 19982-07-1 | C14H23NO | 221.35 |
1,2-Dimethyl Adamantane | 16207-81-1 | C12H20 | 164.29 |
1,4-Dimethyl Adamantane | N/A | C12H20 | 164.29 |
1-Amino-3, 5, 7-Trimethyl-Adamantane HCl | 15210-60-3 | C13H23N HCl | 193.33 36.46 |
1,3,5-Trimethyl Adamantane | 707-35-7 | C13H22 | 178.32 |
1-Hydroxy-3,5-dimethyladamantane | |||
Memantine Impurity (1-Amino-3-Ethyl Adamantine) | 80121-67-1 | C12H21N HCl | 179.31 36.46 |
Memantine-d6 HCl | 1189713-18-5 | C12H15ND6.HCl | 221.8 |
3-Methyl-1-aminoadamantane HCl | 33103-93-4 | C11H20ClN | 201.74 |
Memantine Impurity IV (1-Amino-3-Hydroxy-5,7-Dimethyladamantane) | 63971-25-5 | C12H21NO | 195.31 |
Memantine-d3 HCl | C12H18ND3.HCl | 182.33 36.46 | |
1-Chloro-3,5-dimethyladamantane | 707-36-8 | C12H19Cl | 198.74 |
1,3-Dimethyladamantane | 702-79-4 | C12H20 | 164.29 |
Memantine Impurity B | 941-37-7 | C12H19Br | 243.19 |
MPP-d3 Iodide (1-methyl-4-phenylpyridinium-d3 iodide) | C12H9ND3.I | 173.25 126.90 | |
Meclizine DiHCl | 1104-22-9 | C25H27ClN2.2 HCl | 390.96 2 36.46 |
Meclizine-d8 | 569-65-3 (non-d) | C25H19ClN2D8 | 398.99 |
Meclizine N-Oxide (N4-oxide) | C25H27ClN2O | 406.96 | |
Meclizine N-Oxide (N1-oxide) | C25H27ClN2O | 406.96 | |
Meclizine N-Oxide (N, N'-dioxide) | C25H27ClN2O2 | 422.96 | |
Meclizine-d8 dihydrochloride | C25H19ClN2D8.2 HCl | 399.01 2 36.46 | |
Milnacipran Hydrochloride | 101152-94-7 | C15H22N2O.HCl | 246.36 36.46 |
L-Milnacipran-d5 | N/A | C15H17N2OD5 | 251.39 |
D-Milnacipran-d5 | N/A | C15H17N2OD5 | 251.39 |
L-Milnacipran trans Isomer | C15H22N2O.HCl | 246.36 36.46 | |
Milnacipran | 92623-85-3 | C15H22N2O | 246.36 |
Milnacipran-d10 | 92623-85-3 (non-d) | C15H12N2OD10 | 256.42 |
L-Milnacipran | C15H22N2O | 246.36 | |
D-Milnacipran | C15H22N2O | 246.36 | |
Milnacipran-d5 HCl | 101152-94-7 (non-labelled) | C15H17N2OD5.HCl | 251.39 36.46 |
Milnacipran Carbamoyl-O-Glucuronide | N/A | C22H30N2O9 | 466.49 |
N-Desethyl Milnacipran | 105310-07-4 | C13H18N2O | 218.3 |
N-Desethyl Milnacipran-d5 | N/A | C13H13N2OD5 | 223.33 |
Metformin-d6 HCl | 657-24-9 (non-d) | C4H5N5D6.HCl | 135.20 36.46 |
Metformin Hydroxy Analog Impurity | C2H6N4O | 102.1 | |
Metformin HCl | C4H11N5.HCl | 129.17 36.46 | |
Metformin EP Impurity B (Monoguanyl Melamine) | 07-08-4405 | C4H8N8 | 168.16 |
N,N-Dimethyl Melamine | C6H12N8 | 196.22 | |
Metformin Impurity D | C3H6N6 | 126.12 | |
Metformin Impurity C | 1985-46-2 | C5H10N6 | 154.18 |
Metformin Impurity E (1-Methylbiguanide) Sulfate | 36801-25-9 | C3H9N5. H2O4S | 115.14 98.08 |
Metformin Impurity F | C4H12N6 | 144.18 | |
Methimazole-d3 | 60-56-0 (non-d) | C4H3N2SD3 | 117.19 |
Methimazole (Thiamazole) Impurity B | 616-47-7 | C4H6N2 | 82.11 |
Medroxyprogesterone acetate | 520-85-4 | C24H34O4 | 386.54 |
Medroxyprogesterone Glucuronide | N/A | C28H40O9 | 520.63 |
Medroxyprogesterone acetate impurity F (4,5-beta-Dihydromedroxyprogesterone acetate) | 69688-15-9 | C24H36O4 | 388.55 |
Medroxyprogesterone EP Impurity C | C24H34O4 | 386.54 | |
Medroxyprogesterone EP Impurity D | C24H34O4 | 386.54 | |
Medroxyprogesterone EP Impurity I | C22H32O3 | 344.5 | |
Medroxyprogesterone EP Impurity A | C24H34O5 | 402.54 | |
Medroxyprogesterone EP Impurity F | C24H36O4 | 388.55 | |
Medroxyprogesterone EP Impurity E | C24H32O4 | 384.52 | |
Medroxyprogesterone EP Impurity H | C23H32O4 | 372.51 | |
Medroxyprogesterone acetate-13C2-d3 | 520-85-4 (non-d) | C24H31O4D3 | 391.54 |
Medroxyprogesterone acetate-d10 | 520-85-4 (non-d) | C24H24O4D10 | 396.54 |
Medroxyprogesterone 17-Acetate-d3 | 71-58-9 (non-labelled) | C24H31O4D3 | 389.55 |
Medroxyprogesterone (Medroxyprogesterone EP Impurity B) | 520-85-4 | C22H32O3 | 344.5 |
Medroxyprogesterone-d3 | 162462-69-3 | C22H29O3D3 | 347.52 |
Medroxyprogesterone-d7 | N/A | C22H25O3D7 | 351.54 |
Medroxyprogesterone-13C-d3 | N/A | C22H29O3D3 | 348.51 |
1,2-Dehydro Medroxyprogesterone | 3660-13-7 | C22H30O3 | 342.48 |
M-462 | |||
DL-Methionine | C5H11NO2S | 149.21 | |
Methyl 4-Acetamido-5-Bromo-2-Methoxybenzoate | C11H12BrNO4 | 302.13 | |
Mebeverine HCl | 2753-45-9 | C25H35NO5. HCl | 429.56 36.46 |
Desmethyl Mebeverine Alcohol-d5 | C15H20NO2D5 | 256.4 | |
Desmethyl Mebeverine Alcohol | C15H25NO2 | 251.37 | |
Mebeverine Alcohol-d5 | C16H22NO2D5 | 270.43 | |
Mebeverine Alcohol HCl | C16H27NO2. HCl | 265.40 36.46 | |
Mebeverine-d6 HCl | C25H29NO5D6.HCl | 435.60 36.46 | |
Desmethyl Mebeverine acid | 586357-02-0 | C15H23NO3 | 265.36 |
Desmethyl Mebeverine Acid-d5 | C15H18NO3D5 | 270.39 | |
Mebeverine alcohol (MAL) | C16H27NO2 | 265.4 | |
Mebeverine Acid HCl | 475203-77-1 (free base) | C16H25NO3. HCl | 279.38 36.46 |
Desmethyl Mebeverine Acid-d6 | C15H17NO3D6 | 271.39 | |
DMAC acyl glucuronide | C21H31NO9 | 441.48 | |
DMAC phenolic glucuronide | C21H31NO9 | 441.48 | |
Mitiglinide | 145375-43-5 | C19H25NO3 | 315.42 |
Mitiglinide-d5 | 145375-43-5 (non-labelled) | C19H20NO3D5 | 320.45 |
Mitiglinide acyl glucuronide | C25H33NO9 | 491.54 | |
Mitiglinide calcium | 207844-01-7 | C38H48CaN2O6 . 2 H2O | 668.90 2 18.02 |
Mitiglinide Impurity I | N/A | C19H25NO3 | 315.42 |
(2R)-Mitiglinide Calcium Salt Monohydrate | 1266354-02-2 (anhydrous) | C19H24NO3. 0.5 Ca . H2O | 314.41 0.5 40.08 18.02 |
Mitiglinide impurity E | C19H25NO4 | 331.42 | |
Mitiglinide Impurity B | N/A | C11H12O4 | 208.22 |
Mitiglinide Impurity C | C19H25NO3 | 315.42 | |
Mildronate-d3 | 76144-81-5 (non-labelled) | C6H11N2O2D3 | 149.21 |
Mildronate | 76144-81-5 | C6H14N2O2 | 146.19 |
Methocarbamol | 532-03-6 | C11H15NO5 | 241.25 |
Methocarbamol-d5 | 532-03-6(non-d) | C11H10D5NO5 | 246.28 |
Methocarbamol glucuronide | C17H23NO11 | 417.37 | |
Methocarbamol sulfate | C11H15NO8S | 321.31 | |
Methocarbamol-13C-d3 | NA | C11H12NO5D3 | 245.25 |
Metamizole Sodium Salt (Dipyrone) | 68-89-3 | C13H16N3NaO4S | 333.34 |
Comments
Post a Comment